ARCHIVES

FDA Breakthrough Designation Granted to Pfizer’s Palbociclib

This article is from The Cancer Letter archive.

Vol. 36 No. 4 | April 26, 2013

Download PDF Visit The Full Archive

Related Articles

NIH Authorization Set For Another Try; Women’s Cancers Are Targeted

July 10, 1992

Fisher, interim NSABP Leadership Enter Third Day Of Negotiations To Settle Suit, Aver Court Battle

September 30, 1994

In Brief: NCI Can Proceed With Grant, Contract Awards At Full FY 1978 Level; Rundles Heads ACS

November 18, 1977

CMS Unable to Adjust Cuts To Cancer Care

June 7, 2013

Hatfield, Kennedy Bill would Establish Panel for Clinical Research

February 16, 1996

DCT Board Approves Continuing Neutron Trials Pas 1989 Expiration, With New Funding Plan

June 10, 1988